Arcus Biosciences (RCUS) Operating Margin (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,278.00 |
| Dec 31, 2025 | 20,070.00 |
| Sep 30, 2025 | -54,115.00 |
| Jun 30, 2025 | 43,071.00 |
| Mar 31, 2025 | -3,956.00 |
| Dec 31, 2024 | -17,740.00 |
| Sep 30, 2024 | 5,304.00 |
| Jun 30, 2024 | -26,076.00 |
| Mar 31, 2024 | 63,897.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 3,621.00 |
| Jun 30, 2023 | 5,779.00 |
| Mar 31, 2023 | -12,635.00 |
| Dec 31, 2022 | -553.00 |
| Sep 30, 2022 | 4,343.00 |
| Jun 30, 2022 | 11,667.00 |
| Mar 31, 2022 | -45,147.00 |
| Dec 31, 2021 | 90,512.00 |
| Sep 30, 2021 | -2,114.00 |
| Jun 30, 2021 | -3,582.00 |